Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/23/2867520/0/en/Theriva-Biologics-Announces-Positive-Topline-Data-from-Investigator-Sponsored-Phase-1-Trial-of-Intravitreal-VCN-01-in-Pediatric-Patients-with-Refractory-Retinoblastoma.html
https://www.globenewswire.com/news-release/2024/04/22/2867248/0/en/Theriva-Biologics-to-Present-Preclinical-Data-Supporting-the-Potential-Synergy-of-VCN-01-and-First-Line-Pancreatic-Cancer-Chemotherapy-Regimens-at-the-American-Society-for-Cell-and.html
https://www.globenewswire.com/news-release/2024/04/08/2859135/0/en/Theriva-Biologics-Announces-Presentation-at-the-American-Society-for-Cell-and-Gene-Therapy-27th-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/25/2851523/0/en/Theriva-Biologics-Reports-Full-Year-2023-Operational-Highlights-and-Financial-Results.html
https://www.globenewswire.com/news-release/2024/03/19/2848482/0/en/Theriva-Biologics-to-Host-Conference-Call-and-Webcast-to-Discuss-Full-Year-2023-Operational-Highlights-and-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/11/2843693/0/en/Theriva-Biologics-to-Participate-in-the-BIO-Europe-Spring-Conference.html
https://www.globenewswire.com//news-release/2024/02/07/2825141/0/en/Theriva-Biologics-Announces-Positive-Recommendation-from-the-Independent-Data-Monitoring-Committee-of-VIRAGE-the-Phase-2b-Clinical-Trial-of-VCN-01-in-Combination-with-Chemotherapy-.html
https://www.globenewswire.com//news-release/2024/01/16/2809829/0/en/Theriva-Biologics-to-Participate-in-the-B-Riley-Securities-Annual-Oncology-Conference.html
https://www.globenewswire.com//news-release/2023/11/13/2779007/0/en/Theriva-Biologics-Reports-Third-Quarter-2023-Operational-Highlights-and-Financial-Results.html